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Abstract
Background: Intracellular magnesium is abundant, highly regulated and plays an important role in
biochemical functions. Despite the extensive evidence for unique mammalian Mg2+ transporters,
few proteins have been biochemically identified to date that fulfill this role. We have shown that
epithelial magnesium conservation is controlled, in part, by differential gene expression leading to
regulation of Mg2+ transport. We used this knowledge to identify a novel gene that is regulated by
magnesium.
Results:  Oligonucleotide microarray analysis was used to identify a novel human gene that
encodes a protein involved with Mg2+-evoked transport. We have designated this magnesium
transporter (MagT1) protein. MagT1 is a novel protein with no amino acid sequence identity to
other known transporters. The corresponding cDNA comprises an open reading frame of 1005
base pairs encoding a protein of 335 amino acids. It possesses five putative transmembrane (TM)
regions with a cleavage site, a N-glycosylation site, and a number of phosphorylation sites. Based on
Northern analysis of mouse tissues, a 2.4 kilobase transcript is present in many tissues. When
expressed in Xenopus laevis oocytes, MagT1 mediates saturable Mg2+ uptake with a Michaelis
constant of 0.23 mM. Transport of Mg2+ by MagT1 is rheogenic, voltage-dependent, does not
display any time-dependent inactivation. Transport is very specific to Mg2+ as other divalent cations
did not evoke currents. Large external concentrations of some cations inhibited Mg2+ transport
(Ni2+, Zn2+, Mn2+) in MagT1-expressing oocytes. Ca2+and Fe2+ were without effect. Real-time
reverse transcription polymerase chain reaction and Western blot analysis using a specific antibody
demonstrated that MagT1 mRNA and protein is increased by about 2.1-fold and 32%, respectively,
in kidney epithelial cells cultured in low magnesium media relative to normal media and in kidney
cortex of mice maintained on low magnesium diets compared to those animals consuming normal
diets. Accordingly, it is apparent that an increase in mRNA levels is translated into higher protein
expression.
Conclusion: These studies suggest that MagT1 may provide a selective and regulated pathway for
Mg2+ transport in epithelial cells.
Background
Magnesium is the second most abundant cation within
the cell and plays an important role in many intracellular
biochemical functions [1]. Despite the abundance and
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importance of magnesium, little is known about how
eukaryotic cells regulate their magnesium content.
Intracellular free Mg2+ concentration is in the order of 0.5
mM which is 1–2% of the total cellular magnesium [2].
Accordingly, intracellular Mg2+ is maintained below the
concentration predicted from the transmembrane electro-
chemical potential. Intracellular Mg2+  concentration is
finely regulated likely by precise controls of Mg2+ entry,
Mg2+ efflux, and intracellular storage compartments [3].
The transporters comprising these pathways have only
begun to be identified.
Few magnesium transporters have been identified at the
molecular level. Schweyen and colleagues have demon-
strated that the mitochondrial RNA splicing2 (Mrs2) gene
encodes a protein that is present in yeast and mammalian
inner mitochondrial membranes [4,5]. Mrs2 mediates
high capacity Mg2+ influx in isolated yeast mitochondria
driven by the inner membrane potential but also trans-
ports a range of divalent cations such as Ni2+, Co2+, and
Cu2+ [6]. Overexpression of Mrs2 increases influx while
deletion of the gene abolishes uptake suggesting that it is
the major mitochondrial system. This data suggests that
Mrs2 protein may mediate Mg2+ transport in mammalian
mitochondria. Nadler et al first identified TRPM7, a
widely expressed member of the transient receptor poten-
tial melastatin (TRPM) ion channel family, that produces
a Mg2+ current in a wide variety of cells [7]. TRPM7 is reg-
ulated by intracellular Mg·ATP levels and is similarly per-
meable to both major divalent cations, Ca2+ and Mg2+, but
also many of the trace elements, such as Zn2+, Mn2+, and
Co2+ [8]. Using a positional cloning approach, Schling-
mann et al [9] and Walder et al [10] found that hypomag-
nesemia with secondary hypocalcemia (HSH) was caused
by mutations in TRPM6, a new member of the TRPM fam-
ily. HSH is an inherited disease affecting both intestinal
and renal Mg2+ absorption [3]. The functional characteris-
tics of the TRPM6 transporter have not been fully eluci-
dated [11,12]. Other magnesium transporters have been
functionally described but they have not been character-
ized at the molecular level [13-18]. It is disparaging that,
despite the significance of cellular Mg2+, only three spe-
cific magnesium transporters have been described in
mammalian cells to date.
Mammalian magnesium homeostasis is a balance of epi-
thelial intestinal magnesium absorption and renal mag-
nesium excretion. The kidney plays a major role in control
of vertebrate magnesium balance, in part, by active mag-
nesium transport within the distal tubule of the nephron
[2]. Using the Madin-Darby canine kidney (MDCK) cell
line obtained from canine distal tubules and immortal-
ized mouse distal convoluted tubule cells (MDCT), we
have shown that Mg2+ entry is through specific and regu-
lated magnesium pathways that are controlled by a variety
of hormonal influences [19]. However these hormones
do not provide selective control as they also affect calcium
and in some cases sodium and potassium transport [19].
Selective and sensitive control of cellular Mg2+ transport is
regulated by intrinsic mechanisms so that culture in
media containing low magnesium results in upregulation
of Mg2+ uptake in these cells. This adaptive increase in
Mg2+ entry was shown to be dependent on de novo tran-
scription since prior treatment of the epithelial cells with
actinomycin D prevented the adaptation to low extracel-
lular magnesium [20]. The data suggest that epithelial
cells can somehow sense the environmental magnesium
and through transcription- and translation-dependent
processes alter Mg2+ transport and maintain magnesium
balance. These conclusions using isolated epithelial cells
are consonant with our views of magnesium conservation
in the intact kidney [2].
In an attempt to identify genes underlying cellular
changes resulting from adaptation to low extracellular
magnesium, we used oligonucleotide microarray analysis
to screen for magnesium-regulated transcripts in epithe-
lial cells. This approach revealed one transcript whose rel-
ative level was dramatically altered by extracellular
magnesium. Thus, this transcript potentially represented a
species of mRNA whose synthesis was regulated by
changes in cell magnesium. In this study, we describe the
identification and characterization of this novel transcript
referred to as MagT1. Our data indicate MagT1 may medi-
ate Mg2+ transport in a wide variety of cells and may play
a role in control of cellular magnesium homeostasis.
Results
Identification of MagT1
With the knowledge that differential gene expression is
involved with selective control of epithelial cell magne-
sium conservation, our strategy was to use microarray
analysis to identify candidates that were up-regulated with
low magnesium. Using Affymetrix GeneChipR technol-
ogy, we showed that 116 DNA fragments were signifi-
cantly increased (p < 0.0002) from the 24,000 mouse
ESTs represented on the chips. The RNA of one of these
was significantly increased, greater than 2-fold, n = 3,
determined by real-time RT-PCR. The full length human
cDNA was identified from clone DKFZp564K142Q3
obtained from RZPD Resource Center, Berlin, in pAMP1
vector and bidirectionally sequenced at NAPS, University
of British Columbia. Based on the cDNA sequence, elec-
trophysiological properties and cation selectivity of the
encoded protein, we designated it as MagT1 for Magne-
sium Transport protein, subtype 1. MgT was not used to
avoid confusion with the bacterial MgtA/B and MgtE mag-
nesium transporters [21,22].BMC Genomics 2005, 6:48 http://www.biomedcentral.com/1471-2164/6/48
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Primary structure of MagT1
MagT1 cDNA comprises 2241-base pairs (bp) with an
open reading frame of 1005 bp that predicts a protein of
335 amino acids with a relative molecular mass of 38,036
Da (Fig. 1). Hydropathy profile analysis suggested that
MagT1 is an integral membrane protein containing five
hydrophobic transmembrane-spanning (TM) α  helical
regions, the first of which is likely cleaved to form the final
product with four TM domains (Fig. 1). MagT1 contains a
N-linked glycosylation site at residue 215 located in the
first extracellular loop. The N-terminal region of MagT1
contains four putative cAMP-dependent protein kinase
phosphorylation sites at residues S73, S108, T153 and
S162 and four possible protein kinase C phosphorylation
sites at residues S38, T48, S103, T111. The short C-termi-
nal cytoplasmic region does not possess any cAMP-
dependent or protein kinase C phosphorylation sites. The
presence of putative phosphorylation sites for protein
Primary amino acid sequence of human hMagT1. Figure 1
Primary amino acid sequence of human hMagT1.  Human MagT1 was aligned with human candidate tumor suppressor 
sequence, N33, and the human implantation associated protein, designated IAP. The six predicted transmembrane domains are 
overlined and numbered. The amino acid numbers corresponding to the MagT1 protein are shown on the left side.  BMC Genomics 2005, 6:48 http://www.biomedcentral.com/1471-2164/6/48
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kinase A and protein kinase C in the cytoplasmic domain
suggests that transport might be regulated by
phosphorylation.
MagT1 is a novel gene located at Xq13.1–13.2
The human origin, chromosomal location, and intron-
exon organization of the MagT1 gene were deduced from
the expressed sequence tag (EST) database and the human
genome data. There may be an alternative splicing of
MagT1 but only one transcript could be seen on the
Northern blot (Fig. 2). Mouse mMagT1 gene is comprised
of 10 exons spanning 41,680 bp located on the X chromo-
some (unplaced). The human hMagT1 gene is composed
of 11 exons spanning 69,137 bp and is also on the X chro-
mosome (Xq13.1–13.2).
A BLAST search yielded a number of poorly characterized
proteins with similar amino acid sequences to MagT1
(Fig. 1). Using the BESTFIT sequence alignment program,
MagT1 shows 100% identity to a human unnamed pro-
tein (GenBank™ CAB66571.1, BAC11592.1), 88% to a
mouse implantation associated protein (GenBank™
NP_080228.1, BAB28739.1, BAB31313.1, AAH03881.1),
87% to a rat implantation associated protein (GenBank™
IAG2_RAT, NP_446398.1, AAB63294.2), 66% (first 131
amino acids) to a human implantation associated protein
(GenBank™ XP_497668) and to an unknown protein
MGC:56218 from the zebra fish (AAH46002.1). MagT1
shares some similarity (65–67%) to the human (Gen-
Bank™ AAH10370.1, AAB18376.1, AAB18374.1, G02297,
N33_HUMAN, NP_006756.1, AAB18375.1), mouse
(GenBank™ BAC25795.1), and rat (GenBank™
XP_214356.1) putative prostate cancer tumor suppressor
protein. There is also some similarity (23–54%) to a
number of un-characterized proteins in Anopheles (Gen-
Bank™ EAA13927.1), Drosophila melanogaster (Gen-
Bank™ AAL68198.1, AAF52636.2, NP_609204.2),
Ochlerotatus trisertiatus (GenBank™ AF275675.1), and
Caenorhabditis elegans (GenBank™ NP_498691.1,
AAA28222.1, S44911, Y013_CAEEL). None of these pro-
teins, with similar amino acid sequences to MagT1, are
sufficiently characterized to suggest a common functional
purpose. MagT1 has a more distant relationship (P = 3 ×
10-12) to the OST3 gene of Saccharomyces cervisiae that
encodes a regulatory subunit of the endoplasmic reticu-
lum oligosaccharyltransferase complex [23]. A gapped
alignment of these sequences showed only 21% identical
residues between the hMagT1 and OST3 sequences
extending throughout most of both proteins.
Tissue distribution of MagT1 expression
Northern analysis of cultured mouse distal convoluted
tubule cells and tissues harvested from mice revealed a
single strong transcript of about 2.4 kb (Fig. 2). The kid-
ney, colon, heart and liver possessed relatively high levels
of MagT1 mRNA and smaller amounts were found in
intestine, spleen, brain, and lung (Fig. 2). Accordingly,
MagT1 mRNA appears to be widely expressed among tis-
sues but the transcript is variably expressed among these
tissues.
The MagT1 antibody recognized two protein bands, 35
and 38 kDa, in tissues expressing the MagT1 transcript
(Fig. 3). Two bands were apparent in kidney and liver tis-
sue whereas one was evident in heart, colon, and brain.
The molecular size of MagT1 calculated from cDNA is 38
kDa. A significant difference in the calculated molecular
size and that the smaller band found by immunoblot
analysis raises the possibility that MagT1 may be cleaved
to yield the 35 kDa carboxyl-terminal protein detected by
MagT1 antibody. There was very little MagT1 protein in
the small intestine (Fig. 3). Other than liver tissue, there
appears to be a good correlation between the respective
amounts of transcripts and the protein content. The dis-
crepancy between the levels of MagT1 mRNA and protein
expression in liver (abundant mRNA detected but little
protein detected) suggests that a posttranslational mecha-
nism may play a role in tissue-specific expression of the
MagT1 protein. In summary, the 38 kDa MagT1 protein is
expressed to a variable extent in all of the tissues sampled
(Fig. 3) but the 35 kDa band appears to be present in only
some of the tissues. Although this is a limited survey of tis-
sues, the results suggest that MagT1 is expressed in many
tissues with an apparent correlation of mRNA and protein
but expression may be post-translationally modified in a
tissue-specific fashion such as the liver.
The specificity of the affinity-purified polyclonal anti-
MagT1 antibody was assessed by Western blots of the total
protein extract from the MDCT cells probed with a preim-
mune serum. No protein of the predicted size (~35 kDa)
was detected when the preimmune serum was used (Fig.
3). Taken together, the results indicate that the affinity-
purified anti-MagT1 antibody specifically reacts with the
endogenous MagT1 protein.
Human MagT1 elicits Mg2+-evoked currents in Xenopus 
oocytes
The functional properties of MagT1-evoked Mg2+ currents
were characterized using two-microelectrode voltage
clamp analysis in Xenopus oocytes injected with hMagT1
cRNA. The electrophysiological data gave evidence for a
rheogenic process with inward currents in hMagT1 cRNA-
injected oocytes whereas there were no appreciable cur-
rents in control H2O- or total poly(A)+RNA-injected cells
from the same batch of oocytes (Fig. 4). Human MagT1-
mediated Mg2+-evoked uptake was linear for at least 20
min and did not display any time-dependent decay during
repetitive stimulation with voltage steps (data not
shown). The reversal potential was significantly shifted toBMC Genomics 2005, 6:48 http://www.biomedcentral.com/1471-2164/6/48
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Tissue distribution of mMagT1 mRNA.  Figure 2
Tissue distribution of mMagT1 mRNA. A, Northern blot analysis of mMagT1 mRNA in MDCT cells or mouse tissues. Tissues 
were harvested and poly(A)+ RNA prepared by standard techniques. Each lane was loaded with 8 µg of poly(A)+ RNA. The 
same blot was stripped and hybridized with 32P-labeled β -actin as a control for loading. B, real-time reverse transcription PCR 
analysis of mMagT1 RNA in tissues harvested from mice maintained on normal magnesium diet.  mMagT1 and murine β -actin 
RNA was measured with Real-Time RT PCR (AB7000TM, Applied Biosystems) using SYBR GreenTM fluorescence. Standard 
curves for MagT1 and  β -actin were generated by serial dilution of each plasmid DNA. The expression level of the mMagT1 
transcript was normalized to that of the mouse  β -actin transcript measured in the same 1.0 µg RNA sample. Results are nor-
malized to the small intestine and expressed as fold-difference. Mean mRNA levels of kidney, colon, heart, brain, lung, and liver 
tissues were significantly greater, p>0.01, than small intestine ans spleen.   BMC Genomics 2005, 6:48 http://www.biomedcentral.com/1471-2164/6/48
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the right as would be expected of a magnesium transporter
(Fig. 5). In consonant with the notion that MagT1 protein
mediates the observed Mg2+ currents is the association of
the magnitude of the Mg2+-evoked current with the quan-
tity of MagT1 protein in oocytes injected with MagT1
cRNA (Fig. 6). In this study oocytes were selected accord-
ing to the size of the Mg2+-evoked current and Western
blotting performed on the same oocyte. Both 38 and 35
kDa molecular size bands were correlated with the meas-
ured currents. Steady-state Mg2+-evoked currents were sat-
urable (Fig. 7). The Michaelis constant (Km) was 0.23 mM,
n = 29, when measured at -125 mV holding potential (Fig.
7, insert). The Michaelis constant was independent of the
Vm used to determine the saturation kinetics. The Michae-
lis constants (Km) were +25 mV, 0.22 mM; -50 mV, 0.19
mM; -75, 0.20 mM; -100 mV, 0.19 mM; -125 mV, 0.23; -
150 mV, 0.23 mM (data not shown).
The Mg2+-evoked currents were not altered with deletion
of external sodium by substitution with choline (89 ± 9
%, n = 3, of control currents) or replacement of chloride
with nitrate (100 ± 1 %, n = 3, of control) suggesting that
transport does not depend on extracellular Na+ or Cl-
(data not shown). Niflumic acid (0.5 mM), a Cl- channel
antagonist, did not affect Mg2+ currents (data not shown).
Next, we determined the effect of transmembrane H+ gra-
dients on Mg2+-evoked currents in MagT1-injected oocytes
(Fig. 8). Currents are maximal at physiological pH, 7.4,
and diminished with acidic and alkaline pH values (Fig.
8). Moreover, amiloride (0.1 mM), a Na+/K+ exchange
inhibitor, did not influence expressed Mg2+ currents in
oocytes (data not shown). This data suggests that Mg2+-
evoked currents are not coupled to H+ movement but are
sensitive to external pH. On balance, these data indicate
that Mg2+-evoked currents in MagT1-injected oocytes are
not coupled to Na+, Cl-, or H+ but are influenced by exter-
nal pH values.
Figure 3
Tissue distribution of mMagT1 protein. Figure 3
Tissue distribution of mMagT1 protein. A. Western blots of 
membrane proteins from tissue extracts. Extracts were pre-
pared from tissues as described under “Experimental Proce-
dures”. MagT1 bands were probed with anti-MagT1antibody. 
Molecular sizes are expressed in kDa of pre-stained stand-
ards are shown on the left of each of the representative 
blots. B, summary of 38 kDa MagT1 protein in 15 µg total 
protein from various mice tissues. Data were obtained from 
3 different mice and are indicated as the mean ± SEM. C, spe-
cificity of anti-MagT1 antibody. The fractions isolated from 
normal and magnesium-depleted MDCT cells were blotted 
with MagT1 antibody and MagT1 antibody preadsorbed with 
excess antigen peptide. The signal was reduced to back-
ground levels when preadsorbed antibody was used indicat-
ing that the antibody was specific to MagT1. BMC Genomics 2005, 6:48 http://www.biomedcentral.com/1471-2164/6/48
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Large concentrations (2 mM) of Ca2+, or its analogs, Sr2+
and Ba2+ or the other divalent cations tested, Fe2+, Cu2+,
Co2+, Zn2+, Mn2+, and Ni2+, did not produce appreciable
currents in the absence of Mg2+  in hMagt1-expressing
oocytes (Fig. 9). In the experiments shown, the permeabil-
ity ratios (Erev for tested cation relative to Erev for Mg2+)
were corrected for changes in membrane resistance caused
by the respective divalent cation using values from H2O-
injected oocytes (Fig. 9).
Some divalent cations inhibited Mg2+-evoked currents at
relatively large concentrations of the respective inhibitor,
0.2 mM, in the presence of 2.0 mM MgCl2 (Fig. 10). The
cations Ni2+and Zn2+ markedly shifted the ∆ Erev to the left
whereas Mn2+was less effective and Gd3+, Cd2+, Co2+ and
Cu2+ were modest inhibitors (Fig. 10). The multivalent
cation, Gd3+, is a nonselective channel blocker that
inhibits most Ca2+-permeable channels and known TRP
channels [24]. The presence of 0.2 mM (Fig. 10) or 10.0
mM Ca2+, 98 ± 8 % (data not shown), was without effect
on the amplitude of Mg2+-evoked currents. Fe2+ had no
influence on MagT1-mediated currents (Fig. 10). On bal-
ance, these data indicate that hMagT1 cRNA-induced
transport in oocytes is highly selective for Mg2+. Other
divalent cations may be blockers but our evidence is that
they are at most very weak agonists.
We have shown that relatively high concentrations of 1,4-
dihydropyridine analogues, organic blockers of L-type
Ca2+ channels, inhibit Mg2+ entry into distal tubule epithe-
lial cells [19,20]. In the present experiments, nifedipine
(10 µM) did not inhibit Mg2+-evoked currents (0.61 ±
Mg2+-evoked currents in Xenopus oocytes expressing  hMagT1 RNA transcripts. Figure 4
Mg2+-evoked currents in Xenopus oocytes expressing 
hMagT1 RNA transcripts. Current was continuously moni-
tored in a single oocyte expressing hMagT1 clamped at -100 
mV and superfused for the period indicated, first with modi-
fied Barth’s solution containing 0 mM magnesium then with 
2.0 mM magnesium and finally returning to magnesium-free 
solution. 
Mg2+-evoked currents in Xenopus oocytes expressing  hMagT1. Figure 5
Mg2+-evoked currents in Xenopus oocytes expressing 
hMagT1. Current-voltage relationships obtained from linear 
voltage steps from -150 mV to +25 mV in the presence of 
Mg2+-free solutions or those containing the indicated con-
centrations of MgCl2. Oocytes were clamped at a holding 
potential of -15 mV and stepped from -150 mV to +25 mV in 
25 mV increments for 2 s at each of the concentrations indi-
cated. Shown are average I-V curves obtained from control 
H2O-injected (n = 13) or MagT1-expressing (n =/>7) 
oocytes. Note, the positive shift in reversal potential, indi-
cated by arrows, with increments in magnesium concentra-
tion. Values are mean ± SEM of observations measured at the 
end of each voltage sweep for the respective Mg2+ concen-
tration. BMC Genomics 2005, 6:48 http://www.biomedcentral.com/1471-2164/6/48
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0.08 µA at -125 mV, n = 5) but its analogue nitrendipine
(10 µM) was an effective inhibitor (0.15 ± 0.02 µA, n = 7)
in MagT1 expressed oocytes (Fig. 11). Control Mg2+-
induced currents were 0.59 ± 0.09 µA, n = 6, in this series
of experiments (Fig. 11). These findings were similar to
our experience with MDCK and MDCT epithelial cells
[19,20]. Again in consonant with our previous studies, the
channel agonist, BAY K8644 (10 µM) stimulated Mg2+-
evoked currents in expressing oocytes (0.80 ± 0.18 µA, n =
5) supporting the above electrophysiological data that
MagT1 is a channel-like protein (Fig. 11).
MagT1 expression is responsive to magnesium
The rationale for these studies is based on the observation
that renal magnesium conservation is principally
regulated by differential expression of genes encoding
magnesium transport proteins. Accordingly, we deter-
mined the response of MagT1 to changes in magnesium at
the messenger and protein levels. These studies were per-
formed with distal tubule epithelial cells, MDCT, cultured
in media containing normal (1.0 mM) or low (nominally
magnesium-free) magnesium concentrations for 16 h and
on kidney cortex tissue harvested from mice maintained
on either normal or magnesium-restricted diets for 5 days.
The mRNA and protein expression was relatively stronger
in cells cultured in low magnesium media and in tissue of
mice maintained on low magnesium diets (urine and
plasma magnesium concentration, 1.1 ± 0.3 and 0.13 ±
0.01 mM, respectively) compared to normal cells and tis-
sue of animals on normal diets (urine and plasma magne-
sium, 13.2 ± 1.2 and 0.75 ± 0.09 mM, respectively).
MDCT and tissue mMagT1 mRNA, as measured by real-
time RT-PCR was increased by 2.1-fold and 2.3-fold,
respectively (Figure 12). In association with the increases
in mRNA, MagT1 protein was increased by 31 ± 12% in
the cultured epithelial cells and 33 ± 6 % in kidney cortex
with low magnesium relative to the respective controls
(Figure 13). Accordingly, it is apparent that an increase in
mRNA levels is translated into higher protein expression
and by inference leads to greater magnesium transport
(the latter conclusion is based on the urinary magnesium
excretion of animals maintained on low magnesium rela-
tive to normal diets).
Discussion
Despite the extensive evidence for unique mammalian
Mg2+ transporters, few proteins have been biochemically
identified to date that fulfill this role. Moreover,
functional characterization has not been fully investigated
for those that have been reported [11,12]. With the
knowledge that the kidney, particularly the distal tubule,
regulates magnesium conservation through transcrip-
tional mechanisms, we used oligonucleotide microarray
analysis to identify MagT1, a novel Mg2+  transporter
[2,19]. The MagT1 transcript is a 2.4-kb mRNA that
encodes a protein comprising a relatively long N-terminal
segment, a putative region of four TM domains, and a
short C-terminal sequence. The cytoplasmic segments
possess a number of characteristic phosphorylation
motifs. MagT1 shows no structural similarity to any
known transporter. Functional expression of MagT1 in
oocytes results in large Mg2+-evoked currents with little
permeability to other divalent cations. However, some
divalent cations, Ni2+, Zn2+, and Mn2+inhibit Mg2+-evoked
currents at relatively large external concentrations. These
cations are not found in the extracellular or intracellular
fluid at the concentrations used here, 0.2 mM. The other
major extracellular divalent cation, Ca2+, was neither
transported nor were Mg2+-evoked currents inhibited by
extracellular Ca2+. MagT1 is widely distributed among tis-
sues particularly those of epithelial structure. Finally,
MagT1 expression is regulated in these tissues by external
magnesium as predicted by our starting premise. Accord-
ingly, MagT1 fulfills the role of a dedicated mammalian
magnesium transporter. The function of MagT1 in cellular
Mg2+ balance remains to be determined.
The electrophysiological characteristics of MagT1
expressed in Xenopus oocytes are reminiscent of our obser-
vations of Mg2+ transport in intact renal epithelial cells
Association of Mg2+ currents with the expression of 38 kDa  MagT1 protein in Xenopus oocytes injected with MagT1  cRNA. Figure 6
Association of Mg2+ currents with the expression of 38 kDa 
MagT1 protein in Xenopus oocytes injected with MagT1 
cRNA. Oocytes were selected from one frog according to 
the expressed Mg2+ currents as shown. Results illustrated is 
representative of four oocyte preparations from different 
animals. The relative amplitude of Mg2+ currents was associ-
ated with the amount of MagT1 protein determined by 
Western blot analysis.  BMC Genomics 2005, 6:48 http://www.biomedcentral.com/1471-2164/6/48
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measured by microfluorescence [19]. There is not a suita-
ble isotope of Mg2+ for use in physiological experiments
so that we have used fura-mag-2 fluorescence to investi-
gate Mg2+ transport [25]. We have shown that Mg2+ uptake
in a variety of epithelial cells is driven by the electrochem-
ical gradient of Mg2+. Membrane hyperpolarization stim-
ulates Mg2+ transport whereas depolarization abrogates
uptake (19). There was no evidence in renal distal tubule
cells for coupling of apical Mg2+ entry to other ions such
as Na+, Cl-, or H+ [19]. Magnesium transport in immortal-
ized mouse distal convoluted tubule (MDCT) cells is
dependent on the transmembrane concentration gradient
and uptake is saturable, as determined by fluorescence.
The apparent affinity constant is in the order of 0.5 mM
that is similar to that observed for MagT1 expressed in
Xenopus oocytes (Fig. 5). This affinity is appropriate for a
physiological role of the transporter in cellular Mg2+ con-
servation [19]. Mg2+-evoked currents in oocytes express-
ing MagT1 is highly specific for Mg2+, an observation that
is again consonant with our views of Mg2+ transport in
MDCT cells and in vivo kidney [19]. The microfluores-
cence experiments suggest that there may be some varia-
bility in cationic inhibition of Mg2+ uptake depending on
the cell-type used so that other transporters may be
Summary of concentration-dependent Mg2+-evoked currents in MagT1-expressing oocytes using a holding potential of -125  mV. Figure 7
Summary of concentration-dependent Mg2+-evoked currents in MagT1-expressing oocytes using a holding potential of -125 
mV. Mean ± SEM values are those given in Fig. 1A. Inset illustrates an Eadie-Hofstee plot of concentration-dependent Mg2+-
evoked currents demonstrating a Michaelis constant of 0.23 mM.  BMC Genomics 2005, 6:48 http://www.biomedcentral.com/1471-2164/6/48
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Characterization of Mg2+-evoked currents in Xenopus oocytes expressing hMagT1. Figure 8
Characterization of Mg2+-evoked currents in Xenopus oocytes expressing hMagT1. A, effect of pH on Mg2+-evoked currents. 
Currents were measured in standard solutions containing 2.0 mM MgCl2 at the pH values indicated. B, summary of mean cur-
rents with external pH at a holding potential of -125 mV. Mg2+ did not evoke currents in H2O-injected oocytes at any of the 
pH values tested.BMC Genomics 2005, 6:48 http://www.biomedcentral.com/1471-2164/6/48
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Substrate specificity of MagT1 following application of test cations, 2.0 mM, in the absence of external Mg2+. Figure 9
Substrate specificity of MagT1 following application of test cations, 2.0 mM, in the absence of external Mg2+. For clarity, only 
Mg2+,Cu2+, Mn2+,  and Sr2+ are represented in panel A. Oocytes were clamped at a holding potential of -15 mV and stepped 
from -150 mV to +25 mV in 25 mV increments for 2 s for each of the cations. Values are mean ± SEM of currents measured at 
the end of each voltage sweep for the respective divalent cation. B, summary of permeabilities of the tested divalent cations. 
Figure illustrates average permeability ratios (Erev for tested cation relative to  Erev for Mg2+) given in Fig. 9A. BMC Genomics 2005, 6:48 http://www.biomedcentral.com/1471-2164/6/48
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Inhibition of MagT1-mediated currents. Figure 10
Inhibition of MagT1-mediated currents. A,inhibition of Mg2+-evoked currents with 0.2 mM test cation in the presence of exter-
nal 2.0 mM Mg2+.  For clarity, only Cu2+, Mn3+, and Zn2+ relative to Mg2+ are represented. Values are mean ± SEM of currents 
measured at the end of each voltage sweep for the respective cation. B, summary of inhibition by multivalent cations of Mg2+ 
currents based on the change in Erev represented in Fig. 10A. The inhibitor was added with MgCl2 and voltage-clamp was per-
formed about 5 min later.  BMC Genomics 2005, 6:48 http://www.biomedcentral.com/1471-2164/6/48
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Effect of voltage-dependent channel antagonists on MagT1-mediated currents. Figure 11
Effect of voltage-dependent channel antagonists on MagT1-mediated currents. A, the antagonists nifedipine (10 µM) and nitren-
dipine (10 µM), or the agonist, Bay K8644 (10 µM), were added prior to determining Mg2+-evoked currents. B, summary of 
mean currents (I µA) with the respective inhibitors at a holding potential (Vm) of -125 mV (n=7). The analogues were added 5 
min prior to voltage-clamping.  BMC Genomics 2005, 6:48 http://www.biomedcentral.com/1471-2164/6/48
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present with differing selectivity that are tissue specific
[26]. Relatively large concentrations of nitrendipine, a
1,4-dihydropyridine channel blocker, inhibited Mg2+-
evoked currents in MagT1-expressing oocytes not unlike
the inhibition of Mg2+ entry into distal epithelial cells
[19]. Intriguingly, nifedipine did not influence Mg2+-
induced currents in MagT1-expressing oocytes that is sim-
ilar to our previous reports using MDCT cells [19].
Although both antagonists are dihydropyridines, they
have differing efficacy based on their structural differences
[27]. Again, reminiscent of our observations using MDCK
and MDCT epithelial cells, the channel agonist, BAY
8644, increased Mg2+-evoked currents [19]. The 1,4-dihy-
dropyridines analogues are not highly selective channel
blockers/activators but these findings support the notion
that Mg2+ entry into MagT1-expressed oocytes or distal
epithelial cells is via channel-like proteins. Two other
characteristics are noteworthy. First, Mg2+-evoked currents
in MagT1-expressed oocytes are greater at physiological
pH values relative to acidic pH. This is also true for Mg2+
uptake in distal tubule epithelial cells and magnesium
conservation by the intact kidney in vivo [19]. Magnesium
reabsorption is greater and urinary excretion is less in met-
abolic alkalosis than acidosis. Indeed, magnesium wast-
ing may be sufficient in chronic metabolic acidosis to lead
to hypomagnesemia [2]. Second, the presence of multiple
putative protein kinase A and C phosphorylation sites in
MagT1 may suggest phosphorylation-dependent regula-
tion. We have shown that Mg2+ entry into epithelial cells
is stimulated by peptide hormones, such as parathyroid
hormone, glucagon and calcitonin, that act through pro-
tein kinases A and C [19]. Further studies are needed to
elucidate the mechanisms underlying these phenomena.
On balance, many of the functional characteristics of
MagT1 expressed in oocytes are harmonious with our ear-
lier physiological observations using kidney distal convo-
luted tubule cells.
MagT1 is a membrane protein that may comprise ER, early
and late endosomes or apical and basolateral plasma
membrane fractions. The role of each of these structures in
cellular magnesium homeostasis is poorly understood.
Using single cell spatial imaging, we have previously
shown that intracellular ionized Mg2+ concentration is
heterogenously distributed across the cell [28]. The ER or
sarcoplasmic reticulum normally contains high concen-
trations of Mg2+, ranging from 0.4–2.0 mM, relative to the
cytosolic concentration, 0.5 mM, and nucleus, 0.32 mM.
It is clear that Mg2+ is transported into and out of a variety
of intracellular compartments and there is likely
dedicated magnesium transporters for each event. Further
studies are required to establish the subcellular
localization and intracellular trafficking of Mg2+ and the
role of MagT1 protein.
Our evidence is that the expression of MagT1 mRNA and
protein is responsive to cellular magnesium. The ability of
epithelial cells to selectively respond to the availability of
essential nutrients, such as Zn2+ and Fe2+, is not unique
but the cellular mechanisms are unknown [29,30]. Pre-
sumably epithelial cells may sensitively sense intracellular
nutrient concentration and through transcriptional and
post-translational mechanisms adjust transport rates
appropriately [19,29,30]. Our studies indicate that this
response within the cell is the basis for sensitive and selec-
tive control of magnesium balance in the kidney [19].
Epithelial cells comprising the intestine and kidney are
primarily involved with dietary magnesium absorption,
urinary magnesium excretion, and total body magnesium
homeostasis [2]. Accordingly, MagT1 may, in part, be
responsible for intestinal and renal tubular Mg2+ conser-
vation. In support of this is the observation that the
MagT1 transcript is present in these tissues (Fig. 2). How-
ever, magnesium is necessary in all cells and the wide-
spread distribution of the MagT1 transcript may suggest a
housekeeping role for this transporter. It is also germane
to note that MagT1 mRNA is regulated in all cells investi-
gated. Further studies are needed to define the function of
MagT1 mRNA expression is responsive to magnesium. Figure 12
MagT1 mRNA expression is responsive to magnesium. 
Where indicated MDCT cells were cultured in normal (1.0 
mM) or low (<0.01 mM) magnesium media for 16 h. Kidney 
cortical tissue was harvested from mice on normal (0.05% by 
weight) or low magnesium (<0.01%) diets for 5 days. MagT1 
and murine β -actin RNA was measured with Real-Time RT 
PCR (AB7000TM, Applied Biosystems) using SYBR GreenTM 
fluorescence. Data is from 10-12 PCRs performed on five 
separate cultures or animals in each group maintained on low 
and normal magnesium.BMC Genomics 2005, 6:48 http://www.biomedcentral.com/1471-2164/6/48
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MagT1 in intestine and kidney and the role in overall cel-
lular magnesium balance.
Conclusion
We have identified a novel magnesium transporter, prob-
ably a channel, that is regulated by extracellular magne-
sium. To our knowledge this is the first report of a highly
selective Mg2+ transporter. Its role in cellular magnesium
homeostasis and transepithelial magnesium absorption is
unknown but our evidence from our differential gene
expression studies indicate that it plays an important in
cellular magnesium homeostasis.
Methods
Cell culture and oligonucleotide microarray analysis
Mouse distal convoluted tubule (MDCT) cells were iso-
lated from kidneys and immortalized by Pizzonia et al
(31). The MDCT cell line has been extensively used by us
to study renal magnesium transport [21]. Cells were
grown in Basal Dulbecco's minimal essential medium
(DMEM)/Ham's F-12, 1:1, media (GIBCO) supplemented
with 10% fetal calf serum (Flow Laboratories, McLean,
VA), 1 mM glucose, 5 mM L-glutamine, 50 U/ml penicil-
lin, and 50 µg/ml streptomycin in a humidified environ-
ment of 5% CO2- 95% air at 37°C. Where indicated,
subconfluent MDCT cells were cultured in Mg2+-free
media (Stem Cell Technologies Inc., Vancouver, BC) for 4
h. Other constituents of the Mg2+-free culture media were
similar to the complete media.
Microarray analysis was performed according to the pro-
tocol recommended by Affymetrix http://www.affymet
ric.com. Poly(A)+ RNA was extracted with Poly(A)Pure
(Ambion) from cells cultured in high and low magnesium
media. Twenty Fg RNA was used for cDNA synthesis fol-
lowed by in vitro transcription. The cRNA was biotin-
labeled, fragmented, and the probes hybridized to
Affymetrix MG U74 Bv2 and MG U74 Cv2 arrays (Affyme-
trix, Santa Clara) representing approximately 24,000
mouse transcripts. Detailed protocols for data analysis,
documentation of sensitivity, reproducibility and other
aspects of the quantitative microarray analysis are those
given by Affymetrix. Gene categorization was based on the
NetAffx Database.
Northern blot analysis
Cells were harvested by scraping and total RNA isolated
using TRIzol (Life Technologies, Inc.). In some experi-
ments poly(A)+ RNA was isolated using the Poly(A)Pure
mRNA isolation system (Ambion) following the manu-
facturer's instructions. Samples of total RNA (20 µg) or
poly(A)+  RNA (8 µg) were denatured in 2.2 M
formaldehyde, 50% (v/v) formamide buffer and electro-
phoresed on 0.8% agarose 3 M formaldehyde, 0.02 M
MOPS, 8 mM Na acetate, 1 mM EDTA, pH 7.0 gels. The
size-fractionated RNA was transferred to GeneScreen
nylon membranes (NEN) by downward alkali transfer
and UV crosslinked (Stratagene Stratalinker 1800). Mem-
branes were probed with 32P-labelled probes made from
gene specific inserts represented in the microarray analyt-
ical results. The probe templates were prepared from PCR
products representing inserts using specific primers on
cDNA prepared from MDCT cells. The inserts were ligated
into pGEM-t vector (Promega) following QiaexII gel (Qia-
gen) purification. Blots were prehybridized in 50% forma-
mide, 5 X SSPE, 100 µg/ml denatured sonicated salmon
sperm DNA, 5 X Denhardt's solution, 0.1% SDS for 1 h at
42EC in a rotating hybridization oven (Tyler HI-16000).
Probe was heated to 95EC for 5 min, then added to the
prehybridization solution. Membranes were hybridized
for 16 h at 42EC then washed at high stringency sequen-
tially: 2X [1X SSPE, 0.2% SDS, 28EC] 2X [1X SSPE, 0.4%
SDS, 37EC] 1X [0.1X SSPE, 0.2% SDS, 55EC]. Membranes
were exposed on Kodak X-AR-2 film. In most cases, after
images were obtained, membranes were incubated at
95°C for 1 h in 0.1% SDS to remove the bound probe and
hybridized with a 32P-labelled β -actin probe in order to
normalize loading.
Quantitative analysis of MagT1 transcripts by real-time 
RT PCR
Total RNA of cells was extracted by TRIzol (Invitrogen).
Genomic DNA contamination was removed by DNA-
free™ kit (Ambion) prior to making first strand cDNA.
Standard curves were constructed by serial dilution of a
linear pGEM-T vector (Promega) containing the MagT
gene. The primer set of mouse MagT1 was: forward, 5'-
CCAAAGGGGCTGATACATA-3' and reverse, 5'-ATAGAA-
GAACGATGTGTG-3' and the human MagT1: forward, 5'-
GCAAACTCCTGGCGATACTCC-3' and the human reverse
5'-ACTGGGCTTGACTGCTTCC-3'. PCR products were
quantified continuously with AB7000™ (Applied Biosys-
tems) using SYBR Green™ fluorescence according to the
manufacturer's instructions. The relative amounts of
MagT1 RNA were normalized to the respective human
and mouse β -actin transcripts.
Genomic sequence analysis
The MagT1 cDNA sequence was determined by standard
methods. Data base searching and alignments were per-
formed using BLAST. The nonredundant and EST data
bases were sourced. Protein homology searches were per-
formed by comparing the amino acid query sequence
against SWISSPROT data base. The full-length MagT1
cDNA sequence has been deposited in the GenBank™ data
base (accession human DQ000004, mouse DQ000005).
Western blot analysis
A rabbit polyclonal antibody, anti-MagT1, was raised
against the N-terminal domain of the final cleaved humanBMC Genomics 2005, 6:48 http://www.biomedcentral.com/1471-2164/6/48
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MagT1 protein expression is responsive to magnesium. Figure 13
MagT1 protein expression is responsive to magnesium. Western blots of membrane proteins from cells and tissues as 
described under “Experimental Procedures”. MagT1 bands were probed with anti-MagT1antibody. Data are from four West-
ern blots performed on five separate cultures or animals in each group maintained on low and normal magnesium.  BMC Genomics 2005, 6:48 http://www.biomedcentral.com/1471-2164/6/48
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MagT1 protein using a synthetic peptide, INFPAKGKP-
KRGDTYELQV (amino acid residues 140–158), coupled
to keyhole limpet hemocyanin. Affinity-purified rabbit
anti-human MagT1 antibody was diluted in TBS (Tris-
buffered saline, 20 mM Tris, 200 mM NaCl, pH 7.6) con-
taining 0.5 % BSA at a final concentration about 0.7 µl/
ml. For subcellular fractionation, cells were suspended in
lysis buffer (0.25 M sucrose, 10 mM triethanolamine-ace-
tic acid pH 7.6, 1 mM EDTA) containing protease inhibi-
tors (1 mM PMSF, 2 µg/ml leupeptin, 2 µg/ml aprotinin).
Protein concentrations were determined using Bio-Rad
protein assay reagent. SDS-PAGE was performed accord-
ing to Laemmli. For immunobblotting, the proteins were
electrophoretically transferred to polyvinylidene difluo-
ride membranes (HybondR, Amersham Biosciences) by
semidry electroblotting for 45 min. Western analysis was
performed by incubating the blots with antiMagT1 anti-
body or anti-MagT1 antibody preabsorbed with 50 × anti-
gen peptide (control for antibody specificity) overnight at
4EC followed by three washes with TBS/0.1% Tween-20,
10 min each. The blots were then incubated with 1/
10,000 horseradish peroxidase-conjugated donkey anti-
rabbit secondary (Sigma Aldrich) antibody for 1 h. After
washing three times with TBS/Tween-20, 10 min each, the
blots were visualized with ECL (Amersham Biosciences)
according to the manufacturer's instructions.
Expression of MagT1 in Xenopus oocytes and current 
measurements
The cDNA comprising the open reading frame (ORF) of
MagT1 was amplified from the pAMP1 vector using the
cloning primers (sense: 5'-GATTGGTACCGTGAACAT-
GGCCTC-3'; antisense: 5'-CTTGTCGACCCTCTTTAACT-
CATC-3') and was subcloned into the KpnI and ApaI
restriction sites of the pEYFP-N1 expression vector. The
constructs were linearized and then transcribed with SP6
polymerase in the presence of m7GpppG cap using the
mMESSAGE MACHINE™ SP6 KIT (Ambion) transcription
system. Oocytes were injected with MagT1 complemen-
tary RNA (cRNA) or for control observations, H2O or kid-
ney total poly(A)+ RNA; no Mg2+-induced currents were
detected in the latter.
Xenopus oocytes were prepared and injected with cRNA
and electrophysiological recordings were preformed
according to previously described techniques [32]. Briefly,
defolliculated stage V-VI oocytes were typically injected
with 25 ng cRNA in 50 nl H2O. Oocytes were incubated at
18°C for 3–6 days in multiwell tissue culture plates con-
taining Barth's solution (88 mM NaCl, 1.0 mM KCl, 2.4
mM NaHCO3, 1.0 mM MgSO4, 1.0 mM CaCl2, 0.3 mM
Ca(NO3)2, 10 mM Hepes-NaOH, pH 7.6, 2.5 mM Na-
pyruvate, 0.1 % BSA, 10,000 U/l penicillin, 100 mg/l
streptomycin). To record expressed membrane currents,
the oocytes were placed in a recording chamber (0.3 ml)
and perfused with modified Barth's (96 mM NaCl, 10 mM
Hepes-NaOH) containing various concentrations of
MgCl2, as indicated, in substitution for osmotically equiv-
alent amounts of NaCl. All experiments were performed
at room temperature (21°C).
Steady-state membrane currents were recorded with the
two-microelectrode voltage-clamp technique using a
Geneclamp 500 amplifier (Axon Instruments, Inc.). Elec-
trophysiology consisted of a voltage clamp step profile
consisting of a holding potential of -15 mV, followed by 8
episode series of +25 mV steps of 2 s duration, from -150
mV to +25 mV within an episode duration of 6.14 sec.
Each episode recorded 1536 data points collected at 4 ms
intervals. The data was filtered at the appropriate fre-
quency before digitization. In order to assess the permea-
bility of different divalent cations, we used the shift in the
reversal potentials of the respective cation from the
reversal potentials of Mg2+ currents, ∆ Erev, and calculated
by the permeability ratio by:
Px/PMg = exp/(∆ Erev X F/RT)
where R, T, and F have their standard meanings. Voltage
clamp episodes in the presence of extracellular test cations
were corrected against episodes in the absence of external
test cations.
All experimental conditions were performed on oocytes
harvested from a minimum of 3 different animals.
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